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Abstract
In different primate lentiviruses, three proteins (Vpu, Env and Nef) have been shown to have anti-tetherin activities. SIVden
is a primate lentivirus harbored by a Cercopithecus denti (C. denti) whose genome code for a Vpu gene. We have compared
the activity of HIV-1 Vpu and of SIVden Vpu on tetherin proteins from humans, from C. denti and from Cercopithecus
neglectus (C. neglectus), a monkey species that is naturally infected by SIVdeb, a virus closely related to SIVden but which
does not encode a Vpu protein. Here, we demonstrate that SIVden Vpu, is active against C. denti tetherin, but not against
human tetherin. Interestingly, C. neglectus tetherin was more sensitive to SIVden Vpu than to HIV-1 Vpu. We also identify
residues in the tetherin transmembrane domains that are responsible for the species-specific Vpu effect. Simultaneous
mutation (P40L and T45I) of human tetherin conferred sensitivity to SIVden Vpu, while abolishing its sensitivity to HIV-1 Vpu.
We next analyzed the anti-tetherin activity of the Nef proteins from HIV-1, SIVden and SIVdeb. All three Nef proteins were
unable to rescue virus release in the presence of human or C. denti tetherin. Conversely, SIVdeb Nef enhanced virus release
in the presence of C. neglectus tetherin, suggesting that SIVdeb relies on Nef in its natural host. Finally, while HIV-1 Vpu not
only removed human tetherin from the cell surface but also directed it for degradation, SIVden Vpu only induced the
redistribution of both C. denti and C. neglectus tetherins, resulting in a predominantly perinuclear localization.
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Introduction
Evolution of mammalian species, and of primate species in
particular, has been strongly affected by retroviral infections
[1,2,3,4,5,6]. In defense against retroviruses several species have
evolved cellular protein that can protect cells against retroviral
infection, termed restriction factors. One recently identified
restriction factor, tetherin/BST2/CD317/HM1.24, is a mem-
brane protein that exerts its antiviral effect by retaining retroviral
particles (but also virions of other enveloped viruses) at the surface
of infected cells, thereby strongly reducing viral propagation
[7,8,9,10,11,12]. In a number of cell types, tetherin expression is
induced by type I interferon, and can therefore be considered as
one component of innate immunity [11,13]. In turn, some
retroviruses have evolved a variety of countermeasures that aim
at reducing the level of surface expression of tetherin in infected
cells.
Primate lentiviruses principally use two viral proteins, Nef and
Vpu, to down-regulate surface expression of tetherin
[11,13,14,15,16,17,18,19]. The extent to which downregulation
of tetherin is the consequence of an activity of either of these two
proteins varies widely across primate lentiviral lineages, essentially
as a function of the ability of tetherins from the natural host species
of these viruses to respond to either Nef or Vpu. In viruses that do
not express Vpu, Nef usually mediates anti-tetherin activity. This is
the case for the majority of lentiviruses from non-hominid
primates, best illustrated by the strong ability of Nef from SIVmac
to counteract tetherin from Rhesus macaques [16,18,19,20]. In
contrast, Vpu is the only protein able to down-regulate tetherin in
HIV-1, a property explained by the fact that human tetherin
carries a 5 amino acid deletion in its intracytoplasmic domain that
makes it insensitive to regulation by Nef [3,16].
Between these two extremes, a few viral lineages express both
Nef and Vpu. Some of these viruses, such as SIVcpz, a group of
chimpanzee viruses from which HIV-1 was transmitted to
humans, rely essentially on Nef to counteract tetherin expression,
in spite of the presence of a Vpu protein [6,18,21]. In other
viruses, such as SIVmus, regulation of tetherin is achieved by Vpu
rather than by Nef [18]. The reason why these viruses rely on Vpu
rather than on Nef for regulation of tetherin, in spite of the fact
that the tetherin protein of their natural hosts does not bear a
deletion in their intracytoplasmic domain, remains unclear. One
possible explanation for relying either on Nef or Vpu for
regulation of tetherin is that a number of primate lentiviruses
may have been recently transmitted to their host species and that
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tetherin protein expressed in the new host. Some extent of species-
specificity has been described for the regulatory effect of Vpu
proteins [17,18,22]. Furthermore, the ability of some HIV-1 Vpu
proteins to antagonize macaque tetherin in vitro and in vivo was
reported recently [23].
To gain further insight into primate lentiviral regulation of
tetherin proteins, we have focused our attention on two closely
related monkey viruses, SIVden from C. denti, which expresses a
Vpu protein [24], and SIVdeb from C. neglectus, a virus that
belongs to a lineage phylogenetically close to SIVden but that does
not express a Vpu protein [24,25]. We initially compared the
sensitivity of human, C. denti and C. neglectus tetherins to SIVden
Vpu and HIV-1 Vpu. Counteraction of tetherin antiviral activity
showed a species-specific pattern, and some key residues in Vpu
involved in antagonizing BST2 were identified by mutagenesis.
We then analyzed the effect of Nef proteins from HIV-1, SIVden
and SIVdeb on tetherin from the three host species. Significant
counteraction of tetherin activity was observed only when Nef
from SIVdeb (which does not encode a vpu gene) was used against
tetherin from its natural host, C neglectus. These findings are
discussed from the perspective of the evolutionary forces acting on
the viruses and their hosts.
Results
Comparison and expression of human, C. denti and C.
neglectus tetherin proteins
As shown on figure 1, alignment of tetherin amino acid
sequences from humans, C. denti and C. neglectus reveals a number
of important differences. The first such difference is the deletion of
5 amino acids in the intracytoplasmic domain of human tetherin,
the cause of its insensitivity to Nef proteins [3,16]. In addition,
several notable differences (8 amino acid substitutions and an
insertion of two amino-acids) are also seen between the three
tetherin proteins in the transmembrane (TM) domain, a region
known to command susceptibility to down-regulation of tetherin
by HIV-1 Vpu [13,16,26,27,28,29]. These differences in both the
cytoplasmic and transmembrane regions of tetherin are indicative
of strong potential differences in their susceptibility to down-
regulation by Vpu and Nef proteins.
We generated plasmids expressing human, C. denti and C.
neglectus tetherin sequences tagged with a hemagglutinin (HA)
epitope at their N-terminus. Human epithelial 293T cells, a cell
line that does not express human tetherin unless treated with type I
interferon [11,13], were co-transfected with one of the three
tetherin expression plasmids and with an indicator HIV-1 genome
able to assemble and release HIV-1 virions but that does not
express Vpu or Nef (pNL4.3-DVpuDNef). Tetherin activity was
expressed as the percentage of HIV-1 particles released in the
supernatant, based on HIV-1 p24 Elisa, relative to the amount of
particles released in the absence of transfected tetherin expression
plasmid. Because the readout of our experiments was the ability of
tetherin proteins to inhibit viral particle release, we chose to
normalize the amounts of transfected tetherin expression plasmids
based on this antiviral activity. To determine how much of each of
the three plasmids was to be transfected to achieve comparable
antiviral activity, three serial dilutions (1, 0.3 and 0.1 micrograms)
of the plasmids were transfected in 293T cells together with the
indicator pNL4.3-DVpuDNef genome. As shown on figure 2A,
inhibition of virion release by human tetherin was much stronger
than that obtained with C. denti tetherin or of C. neglectus tetherin, a
phenomenon essentially explained by the higher level of stable
expression of human tetherin in 293T cells, as it can be seen in
figure 2B. Transfection of 1 microgram of C. denti tetherin or of C.
neglectus tetherin expression plasmid reduced pNL4.3-DVpuDNef
virion release to levels that represented 10–15% of those obtained
in absence of tetherin. A comparable level of inhibition was
measured when only 0.1 microgram of human tetherin expression
plasmid was transfected (figure 2A). Therefore, we chose to use
these amounts of the respective plasmids, yielding comparable
levels of tetherin antiviral activity, in all further experiments.
Species-specificity of tetherin antagonism by HIV-1 and
SIVden Vpu
Susceptibility of each of the three tetherin proteins to
antagonism by different Vpu proteins was evaluated by co-
transfecting 293T cells with normalized amounts of tetherin
expression plasmid, together with the indicator pNL4.3-DVpuD-
Nef genome and a plasmid expressing the Vpu protein of HIV-1
or SIVden.
With human tetherin, only HIV-1 Vpu was found to strongly
antagonize the antiviral effect of tetherin (figure 3A), contrasting
with SIVden Vpu, which failed to exert any antagonistic effect.
With C. denti tetherin, the only significant antagonistic effect was
seen with SIVden Vpu, for which the rescue of particle release
reached 60% of that of pNL4.3-DVpuDNef expressed without
tetherin (figure 3B). Mirroring the lack of effect of SIVden Vpu on
human tetherin, HIV-1 Vpu had no significant antagonistic effect
on C. denti tetherin. The tetherin protein of C. neglectus a monkey
species naturally infected by a virus that does not express a Vpu
protein, was moderately but significantly susceptible to antagonism
by SIVden Vpu, but not susceptible to HIV-1 Vpu (figure 3C).
These findings corroborate that the antagonistic properties of the
Vpu protein from a given primate lentivirus are for the most part
specific for the tetherin expressed by its natural host species, a sign
of strong species adaptation of these viruses [17,18,22].
In all of these experiments, we ascertained that the changes in
HIV-1 p24 content of culture supernatants that we observed were
actually related to changes in virion release: as shown on figure 3D,
neither tetherin nor Vpu expression had any effect on overall
expression of HIV-1 Gag in transfected cells.
Although the species-specificity of tetherin antagonism by Vpu
is known to be determined by sequences in the transmembrane
region of tetherin, the role of particular residues in this region
remains unclear. Comparison of the transmembrane domains of
C. denti and C. neglectus tetherins revealed only two differences at
positions 28 (V vs. A) and 43 (L vs. P) in C. denti tetherin
numbering. Comparison of the transmembrane domains of
human and C. denti tetherins revealed eight differences at positions
23, 24, 30, 33, 36, 40 and 45 (in human tetherin numbering) and 2
amino acid indel positions 25–26.
It was reported that amino acid sequences in the transmem-
brane domain of human tetherin is critical for the interaction with
HIV-1 Vpu but the molecular basis behind the Vpu counteraction
of tetherin is still not fully elucidated. An important difference
between human and C. denti/C. neglectus tetherins is the presence of
a 2 amino acid insertion (glycine-isoleucine) in human tetherin at
positions 25–26. These 2 amino acid are deleted in tetherins
proteins from Old World monkeys, but presents in hominoids and
New World Monkeys [3]. Deletion of these two amino acid in
human tetherin only produced an overall drop in HIV-1 Vpu
susceptibility with no increase in SIVden Vpu antagonism
(figure 4A). Similarly, insertion of these two amino-acids in C.
denti tetherin produced a moderate drop in susceptibility to
SIVden Vpu and no change in susceptibility to HIV-1 Vpu
(figure 4B), thereby demonstrating that these two amino-acids play
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tetherin by HIV-1 and SIVden Vpu proteins [3,27,30,31].
We then focused our study on the residue 40P/43L/43P
(human/C. denti/C. neglectus numbering respectively) because of the
divergence between C. denti and C. neglectus and on residue 45T/
48I/48I that was shown to be required for the antagonism by Vpu
[27,31,32]. To evaluate the role of these residues, individual and
combined substitutions were introduced in human tetherin. As
shown on figure 5 A and B, neither of the P40L or T45I
substitutions alone were able to alter the strong specificity of HIV-
1 Vpu for human tetherin, even if the P40L mutation significantly
increased susceptibility of human tetherin to SIVden Vpu. When
both P40L and T45I were expressed together in human tetherin,
however, susceptibility of this mutant protein to HIV-1 Vpu
dropped sharply, while susceptibility to SIVden Vpu increased to
50%, a level close to that observed with wild-type C. denti
tetherin. In contrast, reverse substitutions at these positions in C.
denti tetherin failed to produce a similar clear-cut change in
species specificity (data not shown).
Overall, these findings emphasize that in spite of numerous
differences in the transmembrane region of human tetherin and C.
denti tetherin, most of the species-specificity of their susceptibility
by the two different Vpu proteins tested here are essentially carried
by the combined residues 40 and 45 in human tetherin.
Species-specificity of tetherin antagonism by HIV-1,
SIVden and SIVdeb Nef
In addition to evaluate species-specificity of human, C. denti and
C. neglectus tetherin to different Vpu proteins, we also examined the
extent to which these tetherins were affected by the Nef proteins
from HIV-1, SIVden and SIVdeb. As shown on figure 6A, the
antiviral effect of human tetherin was not affected by any of the
three Nef proteins, consistent with the fact that human tetherin
carries a 5 amino acid deletion in its cytoplasmic domain that
makes it insensitive to down-regulation by Nef [3,16]. None of the
Figure 1. Alignment of tetherin amino acid sequences. A. Alignment of the cytoplasmic tail and transmembrane domains of tetherins from 16
primates. The accession numbers of the sequences used in this figure are: Human NP 004326; Gorilla gorilla ADI58594; P. troglodytes ADI58593; P.
paniscus ADI58595; C. nictitans ACX46125; C. mona ACX46126; C. cephus ACX46508; P. nemaeus ADI58604; C. aethiops ADI58600; E. patas ADI58599; P.
pygmaeus ADI58596; M. mulatta ADI58602; N. leucogenys ADI58597; H. agilis ADI58598; C. guereza kikuyuensis ADI58603; M. talapoin ADI58601. B.
Differences in the TM domain of human, C. denti and C. neglectus tetherins are highlighted in the blue box. Red numbers and letters indicate the
amino acids we mutated in this study. In both panels, amino acid identity is indicated by dots and sequence gaps are indicated by dashes.
doi:10.1371/journal.pone.0035411.g001
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tetherin (figure 6B), despite that this tetherin displays no deletion
in its cytoplasmic domain. The only tetherin for which some effect
of Nef could be measured was C. neglectus tetherin (Figure 6C): a
small, albeit significant, antagonistic effect of this tetherin was seen
with the Nef protein from SIVdeb, the virus that naturally infects
C. neglectus monkeys. Interestingly, substitution of tryptophan at
position 17 in C. neglectus tetherin by a cysteine, as found in C. denti
tetherin, reduces the extent to which SIVdeb Nef counteracts
BST2 activity on virion release (Figure 6D), suggesting that this
residue participates to the species-specific activity of Nef. Thus,
although clearly not as marked as in the case of Vpu, some extent
of species-specificity can be seen in the counteracting effect of Nef
on the tetherin proteins from the species studied here. Interest-
ingly, the only antagonistic Nef protein was from the virus that
does not express a Vpu protein, an effect that was only found
significant when targeting the tetherin protein from its natural host
species.
Effect of SIVden and HIV-1 Vpu proteins on human and C.
denti tetherin expression profiles
We next examined the mechanisms through which Vpu
proteins antagonized the antiviral effects of the tetherin proteins
studied here. Two mechanisms have been proposed to explain
down-regulation of tetherin by Vpu: accelerated degradation and
redistribution, which results in reduced surface expression but
conserved overall amounts of tetherin protein. Each of the three
tetherin expression plasmids was co-transfected in 293T cells in
the presence or absence of the HIV-1 or SIVden Vpu expression
plasmids. The transfected cells were subjected to western blot
analysis of tetherin content using an anti-HA antibody. As shown
on figure 7A, HIV-1 Vpu had a marked effect on total amounts of
human tetherin. In contrast, SIVden Vpu, which exerted a strong
antagonistic effect on the antiviral properties of C. denti tetherin,
did not produce any change in the total amounts of this protein. As
expected from the results of our experiments evaluating antago-
nism of tetherin antiviral activity, HIV-1 Vpu had no effect on C.
denti tetherin and C. neglectus tetherin expression levels. Similarly,
SIVden Vpu did not reduce cellular amounts of human tetherin
and C. neglectus tetherin.
To further address the possibility that HIV-1 and SIVden Vpu
proteins exerted their antagonistic effects on tetherin through
different mechanisms, we used confocal microscopy to examine
the cellular distribution of tetherin in the absence and presence of
Vpu proteins. Representative images are shown on figure 7B, and
a quantitative analysis, based on random examination of 100 cells
in each of the transfection conditions, is presented on Table 1. In
the absence of Vpu, human tetherin, C. denti tetherin and C.
neglectus tetherin are all localized both at the cell surface and in
intracellular compartments. In the presence of HIV-1 Vpu, the
pattern of expression of human tetherin changed dramatically. In
most cells, the amount of human tetherin expressed became very
weak and diffuse, while in ,10% of cells tetherin expression was
restricted to the perinuclear region. A different pattern was seen
with C. denti tetherin in the presence of SIVden Vpu. In this case,
only redistribution was observed and tetherin was expressed in
cytoplasmic and perinuclear compartments, at the expense of
surface expression. This is fully consistent with the notable impact
of SIVden Vpu protein on C. denti tetherin antiviral activity in spite
Figure 2. Effect of tetherin from different hosts on virus
release. A. Virus particle release was tested in 293T cells transfected
with HIV-1DVpuDNef NL4.3 proviral DNA (500 ng) in the presence of
human, C. denti and C. neglectus tetherin. Virus production expressed as
a percentage of maximal particle release in the absence of tetherin is
shown for increasing amounts of plasmid DNA encoding for the three
tetherin constructs (100, 330 and 1000 ng). Differences in the amount
of plasmid DNA in each transfection were compensated by the addition
of control vector (pcDNA3). After 42 h, the amount of virus released
into cell culture supernatant was measured by HIV-1 p24 ELISA. This
figure is representative of three independent experiments. B. Expression
of Vpu constructs. Western blot analysis was performed to determine
the expression levels of the three plasmids encoding HA-tagged
tetherins. 293T cells were cotransfected with 1000 ng of each plasmid.
Tetherin migrated as several species in SDS-PAGE analyses, presumably
as a result of heterogeneus glycosylation. Forty-two hours after
transfection cell lysates were collected and analyzed by Western blot.
The expression level of HIV-1 Gag protein was monitored with an anti-
p24 antibody. Actin was used as a loading control.
doi:10.1371/journal.pone.0035411.g002
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tetherin seen on western blots.
Discussion
Primate lentiviruses have evolved three distinct mechanisms to
counteract the effects of tetherin, a restriction factor that retains
Figure 3. Effect of Vpu from HIV-1 and SIVden on virus release in the presence of the different tetherin molecules. Viral particle
release from 293T cells was measured after cotransfection of a HIV-1DVpuDNef proviral construct (500 ng) with different tetherin-encoding plasmids:
(A) human (100 ng), (B) C. denti (1000 ng), and (C) C. neglectus (1000 ng), and in the absence or presence of HIV-1 or SIVden Vpu encoding plasmids
(250 ng). (A, B and C). Viral particle release was quantified 24 h post-transfection by p24 ELISA. The amount of p24 antigen produced relative to the
virus yield obtained in the absence of tetherin (100%) is plotted. Results are expressed as mean 6 SD for 5 experiments. The indicated p values
correspond to the comparison with the ‘‘no vpu’’ sample. (D) Forty-two hours after transfection cell lysates were collected and analyzed by Western
blot. The expression level of HIV-1 Gag protein was monitored with an anti-p24 antibody. Actin was used as a loading control. The depicted gel is
representative of three independent experiments. For all viral release assays, the cell-associated p24 was monitored. Molecular weight markers are
shown on the left in kilodaltons.
doi:10.1371/journal.pone.0035411.g003
Antagonism of Tetherin by Lentiviruses
PLoS ONE | www.plosone.org 5 April 2012 | Volume 7 | Issue 4 | e35411virions at the surface of the producer cell, thereby limiting their
ability to spread to new target cells. The majority of these viruses
takes advantage of the multifunctional Nef protein, a protein that,
depending on the virus, also has the ability to downmodulate
surface expression of a variety of host cell membrane proteins such
as CD3, CD4 or MHC class I [6,33]. A subset of Cercopithecus
lentiviruses have acquired a vpu gene [24,34,35], that has the
capacity to interact with the transmembrane region of tetherin, an
interaction that leads to endocytosis and/or accelerated degrada-
tion of the restriction factor [6,17,18]. Of note, the Vpu proteins of
some primate lentiviruses also exert an inhibitory effect on surface
expression of CD4 [6,36]. Finally, in a few viruses for which
neither Vpu nor Nef seem able to counteract tetherin, this function
is achieved by the intracellular domain of their Env protein
[28,37,38].
The evolutionary mechanisms explaining why some primate
viruses rely on Vpu for regulation of tetherin while still expressing
a Nef protein are not fully explained. Differents parameters seems
to have driven evolution towards the use of Nef or Vpu. In
SIVcpz, a virus infecting chimpanzees which was reported to arise
from recent recombination between SIVgsn (a Vpu-expressing
monkey virus) and SIVrcm (a monkey virus without a vpu gene)
[39], the SIVgsn-derived Vpu protein fails to efficiently counteract
chimpanzee tetherin but this function is fulfilled by SIVrcm-
derived Nef [6,17,18]. In humans, a different situation is
encountered: the human tetherin protein carries a deletion of a
5-amino acid motif in its cytoplasmic domain making it insensitive
to Nef, a situation that has probably forced (at least in HIV-1
group M) rapid evolution of a Vpu protein with strong activity
against human tetherin [3,6,16,17,18,19]. Yet another particular
situation is encountered with HIV-2 in humans, as HIV-2 is
derived from SIVsmm, a monkey virus with no vpu gene. Because
it could neither rely on Nef nor on Vpu for down-regulation of
human tetherin, HIV-2 has evolved an Env protein that has
acquired this property [38,40]. Similarly, SIV from Tantalus
monkeys (SIVtan) encodes an envelope glycoprotein able to
counteract tetherin from Tantalus monkeys, rhesus monkeys, sooty
mangabeys, and humans [28].
These observations and assumptions, however, do not fully
explain why, earlier in primate lentiviral evolution, some monkey
viruses have acquired a Vpu protein while others have solely relied
on their Nef protein for counteracting tetherin.
The ability of SIVden Vpu protein to antagonize tetherins was
already addressed [6,18]. In this study we have examined the anti-
Figure 4. Virion release from cells tranfected with vectors expressing tetherin mutants. HIV-1 Vpu and SIVden Vpu were tested for their
ability to rescue p24 release for HIV-1DVpuDNef in 293T cells expressing human tetherin delta 25–26 (A) or C. denti tetherin insertion 28–29 (B).
Twenty-four h after transfection the p24 content of the supernatant from each sample was quantified using a p24 ELISA. and expressed as the
percent of p24 of the control without tetherin. Results are the mean 6 SD for 5 independent experiments. The indicated p values correspond to the
comparison with the «no vpu» sample.
doi:10.1371/journal.pone.0035411.g004
Antagonism of Tetherin by Lentiviruses
PLoS ONE | www.plosone.org 6 April 2012 | Volume 7 | Issue 4 | e35411tetherin activity of two closely related monkey viruses, SIVden
from C. denti, which expresses a Vpu protein, and SIVdeb from C.
neglectus, which does not have a Vpu gene. The tetherin proteins
from these two monkey species are closely related, diverging only
by a few polymorphisms in their cellular and transmembrane
domains, which are known to determine tetherin sensitivity to Vpu
and Nef, respectively.
We first compared the sensitivity of human, C. denti and C.
neglectus tetherins to SIVden Vpu and HIV-1 Vpu (Figure 2). HIV-
1 and SIVden Vpu proteins strongly and almost exclusively
affected the antiviral activity of human and C. denti tetherins,
respectively. Interestingly, C. neglectus tetherin appeared more
sensitive to SIVden Vpu than to HIV-1 Vpu, consistent with the
high homology found between the Vpu-sensitive domains of C.
denti and C. neglectus tetherins.
In our study, the specific activity of SIVden Vpu on C. denti
tetherin was explained by the presence in tetherin of a leucine at
position 40 and of an isoleucine at position 45 fond in C. denti
tetherin. Introduction of these two amino acid simultaneously in
human tetherin reproduced the phenotype observed with wild-
type C. denti tetherin (Figure 3).
The deletion of two amino acids at position 25–26 in human
tetherin, as well as the insertion of the corresponding amino acids
in C. denti tetherin, however, failed to exert any effect on virus-host
specificity (Figure 4).
In this study, we also examined susceptibility of the three
tetherins to the Nef proteins from HIV-1, SIVden and SIVdeb.
Consistent with previous studies, the antiviral activity of human
tetherin was resistant to all three Nef proteins. Clearly, C. neglectus
tetherin was the most sensitive to Nef, an effect that was most
significant using SIVdeb Nef, a finding fully consistent with the
fact that this SIVdeb does not express a Vpu protein and appears
to rely on Nef for counteracting tetherin. Interestingly, introduc-
tion of the W17C substitution in C. neglectus tetherin, which
reproduces the sequence of C. denti tetherin at this site, abrogated
the effect of Nef, emphasizing the importance of this residue in
virus-host adaptation. It is noteworthy that the effect of Nef on C.
neglectus tetherin, although significant, was only partial (30% rescue
of the block in virus release exerted by tetherin), and reminiscent
of observations by Lim et al. with SIVagm from African green
monkeys [3]. As suggested by these authors for SIVagm, it is
possible that in C. neglectus, infection by SIVdeb may induce only
limited induction of interferon type I production, thereby limiting
the amount of tetherin to which the virus is confronted during in
vivo replication. Similarly, the impact of SIVden Vpu on C. denti
tetherin is clearly partial (60%) compared to that observed with
HIV-1 and human tetherin. Again, such partial activity is
suggestive of the fact that C. denti may not need as much
neutralization of tetherin as that required for human infection by
HIV-1. Nonetheless, the fact that SIVden relies essentially on Vpu
for activity on tetherin, and the fact that this effect on C. denti
tetherin is clearly stronger than that of SIVdeb Nef on C. neglectus
tetherin, together suggest that during infection of C. denti, SIVden
may be confronted to higher levels of tetherin expression than
those in SIVdeb-infected C. neglectus monkeys.
These results do not exclude the possibility that the Env protein
from SIVdeb may also participate in antagonizing the antiviral
activity of tetherin, as has been observed for HIV-2 [38,40] and
SIVtan [28], although viruses that employ two different proteins to
inhibit tetherins have not as yet been described. Testing this
possibility will require the identification of functional SIVdeb Env
proteins.
Another interesting finding of our study, pertaining to the
particularly strong activity of HIV-1 Vpu on human tetherin, was
the striking difference observed on the pattern of cellular
expression of the three tetherins tested here in response to the
two Vpu proteins. As shown on figure 5 and table 1, HIV-1 Vpu
almost completely abolished expression of human tetherin,
confirming earlier findings that human tetherin was not only
removed from the cell surface but also directed to an efficient
degradation pathway. In contrast, the activity of SIVden Vpu on
both C. denti and C. neglectus tetherins, only resulted in
redistribution of these proteins, with a predominantly perinuclear
expression. Although it is conceivable that this effect is related to
differences in intrinsic recycling and degradation pathway
targeting properties between HIV-1 and SIVden Vpu proteins,
it is also possible that redistribution and perinuclear expression
without degradation is related to the partial activity of SIVden
Vpu on C. denti and C. neglectus tetherins. In this case the
Figure 5. Identification of the residues responsible for the
species-specific effect of HIV-1 Vpu and SIVden Vpu. Amino acid
substitutions were introduced into full-length human tetherin: (A) P40L,
(B) T45I, (C) P40L+T45I. HIV-1 Vpu and SIVden Vpu were tested for their
ability to rescue HIV-1DVpuDNef virus release in cells expressing the
different human tetherin mutants. Transfection and assay conditions
were the same as described in Figure 4 legend.
doi:10.1371/journal.pone.0035411.g005
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redirecting tetherins to the perinuclear compartment but not
quite sufficient for achieving full targeting to a degradation
compartment.
Our findings endorse the assumption that Vpu and Nef-
mediated tetherin antagonism are original properties of primate
lentiviruses, and the resistance of human tetherin to primate
lentivirus Vpus and Nefs seems to represent a significant barrier to
zoonotic transmissions [6,16,17,18,19].
Materials and Methods
Construction of the plasmid HIV-1DVpuDNef-Renilla
The Vpu region of the plasmid deleted of Nef pNL4-3-lucR
[41] was deleted and replaced by the deletion mutant produced by
Klimkait et al (1990). This mutation comprises a deletion of 48
nucleotides immediately following the initiator methionine codon
of the vpu ORF plus a 7-nucleotide insertion, and results in a
minus-1 frameshift and premature termination after 14 missense
codons [42].
Tetherin cloning
Tetherin genomic regions were PCR amplified from HeLa cells
and from C. denti and C. neglectus uncultured peripheral blood
mononuclear cell (PBMC) DNA. A unique forward primer was
used (59-TGGAACTTGCTATTGGTCAG-39). Two reverse
primers were synthesized, one for human and C. denti tetherins
(59-CCTTCTCACTGGATTCTCC-39) and one for C. neglectus
(59-CCTTCTCACTGGATTCTCA-39).
Splice-overlap-extension PCR was used to splice the introns.
The integrity of all PCR derived cDNAs was confirmed by
sequence analysis.
N-terminal HA-tagged tetherins were obtained by PCR using a
N-terminal primer containing the HA sequence. These products
were cloned into the KpnI-Xho1 sites of pcDNA3.1/CT-GFP-
TOPO (Invitrogen).
Vpu and Nef cloning
The pNG227 plasmid containing four copies of Mason-Pfizer
monkey virus constitutive transport element was a gift of Michael
H. Malim. The two Vpu proteins and the three Nef proteins were
cloned in pNG227 using the XbaI-SalI sites.
Figure 6. Tetherin antagonism by different Nef proteins. HIV-1 Nef, C. denti Nef and C. neglectus Nef were tested for the ability to rescue virus
release using vpu and nef-deficient strain of HIV-1 in the presence of human (A), C. denti (B), C. neglectus (C) and C. neglectus (W17C) (D) tetherin. The
p24 antigen yield was measured from 293T cells cotransfected with a HIV-1DVpuDNef proviral construct (500 ng), with pcDNA3 vectors expressing
the indicated tetherin protein and in combination with plasmids expressing different Nef proteins. Twenty-four h post-transfection, the amount of
virus released into the cell culture supernatant was measured by HIV-1 p24 antigen-capture ELISA. All values are shown relative to those obtained in
the absence of tetherin expression vector (100%). The indicated p values correspond to the comparison with the «no vpu» sample.
doi:10.1371/journal.pone.0035411.g006
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a single HA epitope tag to the ectodomain of the three BST2
proteins by primer-directed mutagenesis using PCR [27].
Overlap-extension PCR approaches were used to insert the HA-
tag at a position 463 nucleotide of human tetherin protein, using
PCR-A primers 59-CCGGTACCATGGCATCTACTTCGTA-
TGA-39 (forward) and 59-AGTCTGGGACGTCGTATGGGT-
ATGCGGCGTAGTACTTCTTGTCCGCGATTCTCAC –39
(reverse), and PCR-B primers 59- CATACCCATACGACGTCC-
CAGACTACGCTGCCCCCAGCTCCCAGGACTCCAGCTC
–39 (forward) and 59- GTCTCGAGTCACTGCAGCAGAGC-
GCTTAGG –39 (reverse). For the monkey tetherins, the HA
epitope was inserted at a position orthologous to nucleotide 463
using primers C. denti tetherin PCR-A 59- CCGGTACCATGG-
CACCTATTTTGTATGACT -39 (forward), 59- GGCAGCG-
TAGTCTGGGACGTCGTATGGGTATGCGGCGGAGTTC-
GTGTCCGCGATT-39 (reverse), PCR-B 59- TACCCATAC-
GACGTCCCAGACTACGCTGCCGCCAGCCCCCAGGAC-
Figure 7. SIV Vpu does not reduce total tetherin levels but leads to depletion of tetherin from the cell surface. (A) 293T cells were
cotransfected with HIV-1DVpuDNef proviral construct (500 ng) and a plasmid encoding HA-tagged tetherins (human (100 ng), C. denti (1000 ng) and
C. neglectus (1000 ng) and with or without HIV-1 Vpu plasmid (250 ng) or SIVden Vpu plasmid (250 ng). The effect of the two Vpu constructs on
tetherin protein levels was monitored by Western blotting, using an anti-HA antibody. Tetherin migrated as several species in SDS-PAGE analyses,
presumably as a result of heterogeneus glycosylation. The depicted gel is representative of three independent experiments. (B) Subcellular
localization of tetherin. 293T cells were cotransfected with 1000 ng of DNA encoding the indicated tetherin proteins (HA-tagged), with a proviral
construct (1000 ng) and with a HIV-1 Vpu or SIV Vpu plasmid (500 ng). 24 h after transfection the cells were fixed, permeabilized, and stained with rat
anti-HA (green) monoclonal antibody (clone 3F10, Roche Applied Science). Nuclei are stained with DAPI (blue). Cells were examined by confocal
microscopy. Images are representative of three independent experiments. Scale bars represent 10 mm.
doi:10.1371/journal.pone.0035411.g007
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CAGCAGAGCGCCCAAG-39 (reverse), respectively. C. neglectus
tetherin primers PCR-A 59- CCGGTACCATGGCACCTAT-
TTTGTATGACT-39 (forward), 59- GCGTAGTCTGGGACG-
TCGTATGGGTATGCGGCGGAGTTCGTGTCCGCGATT-
CTCA-39 (reverse), PCR-B 59- TACCCATACGACGTCCCA-
GACTACGCTGCCAGCCCCCAGGACTCCAGCTGCGCG-
G-39 (forward), and 59- GTCTCGAGTCACAGCAGCAGAGC-
GCCCAAG-39 (reverse), respectively. PCR fragments were cloned
into pcDNA3 vector by inserting a KpnI-XhoI restriction site. All
plasmids were confirmed by nucleotide sequence analyses.
Cell lines
The human cell line 293T were obtained from the American
Type Culture Collection (ATCC Cat No. CRL-11268) and
cultured according to the instructions provided.
Virus yield and tetherin antagonism
To determine the capability of Vpu and Nef to antagonize
tetherin, 293T cells were seeded in a 12-well plate and transfected
with 500 ng of the pNL4.3-DVpuDNef proviral construct, tetherin
expression vectors [human (100 ng), C. denti (1000 ng) and C.
neglectus (1000 ng)], 250 ng mg HIV-1 Vpu or SIVden Vpu
expression plasmids and 600 ng of Nef expressing plasmids. A
pcDNA3 vector (Invitrogen) was used to equalize the DNA
concentration. Transfection were made using jetPEI transfection
reagent (PolyPlus transfection) according to manufacturer’s
recommendations. At 42 hours post-transfection supernatants
were harvested, clarified by centrifugation at 800 g and analyzed
for p24 antigen by an enzyme-linked immunosorbent assay
(ELISA) kit (Innogenetics, Belgium).
Western blot
To monitor tetherin expression, 293T cells were cotransfected
with the indicated amount of N-terminally HA-tagged tetherin
expression constructs [(human (100 ng), C. denti (1000 ng) and C.
neglectus (1000 ng)], proviral constructs pNL4.3-DVpuDNef-Renilla
(500 ng) and HIV-1 Vpu (250 ng) or SIVden Vpu (250 ng)
plasmids. The transfections were made as described above. One
day post-transfection cells were washed once with PBS and lysed in
the sample buffer [50 mM Tris-HCl (pH 6.8), 2% SDS, 100 mM
DTT, 10% glycerol and 0,005% bromophenol blue]. Proteins
were solubilized by heating for 10 min at 95uC. Residual insoluble
material was removed through centrifugation (10 min at 110006
g). Cell lysates were separated on SDS-PAGE and transferred to
Nitrocellulose membranes and probed with anti-HA Rat antibody
(Roche, 3F10, 1:1000 dilution). Specific antibody-antigen com-
plexes were identified using horseradish peroxidase-labeled goat
anti-rat IgG secondary antibodies (AP136P, Millipore) and then
incubated with the chemiluminescent substrate (RPN2135,
Amersham). Densitometry quantification was achieved using
ImageJ software.
For internal controls, blots were re-incubated with mouse
antibodies specific for HIV1 p24 (ab9071, Abcam) and actin (A
2066, Sigma). Subsequently, blots were probed with anti-mouse or
anti-rabbit IRDye antibodies (Odyssey 926-32222, 926-32213)
and proteins revealed using a LI-COR Odyssey scanner.
Confocal microscopy
Subconfluent monolayer of adherent human 293T cells grown
on coverslips in 6-well plates were cotransfected with tetherin
plasmids carrying HA-tag in the ectodomain (1000 ng), with a
proviral constructs pNL4.3-DVpuDNef (1000 ng) and HIV-1 Vpu
or SIVden Vpu (500 ng), and with appropriate amounts of the
empty pcDNA3 vector used as carrier plasmid DNA to normalize
the quantity of DNA transfected per well. The transfections were
made as described above. After 24 hours, cells were fixed with 3%
formaldehyde in PBS for 15 min at room temperature, washed
three times with 50 mM ammonium chloride in PBS. The cells
were incubated with 1% bovine serum albumin in PBS. For
labeling the cell surface, the cells were incubated with anti-HA rat
primary antibodies (Roche, 3F10, 1:2000 dilution) for 1 h. For
permeabilization, cells were treated for 5 min at room tempera-
ture with 0.1% Triton X-100 buffered with PBS. After washing
three times with PBS, non-specific binding was blocked with 1%
bovine serum albumin in PBS for 1 h at room temperature. Cells
were then incubated for 1 h at room temperature with an anti-HA
Rat primary antibodies (Roche, 3F10, 1:2000 dilution). Cells were
washed for 20 min in PBS, and incubated with anti-mouse
immunoglobulin G-Alexa Fluor (IgG-Alexa Fluor 488, 1:500
dilution) for 1 h at room temperature. Finally, cells were washed
again for 20 min in PBS and then mounted using Vectashield+-
DAPI (Vector Laboratories, Burlingame, CA). Cells were then
examined using a LSM ZEISS 510 confocal microscope.
Nucleotide sequence accession numbers
The sequences have been submitted to the EMBL database: C.
denti (HE680870), C. neglectus (HE680871) tetherins and SIVneg
Nef gene (HE680872).
Others accession number are: Nef pNL4.3 (M19921), SIVden
Nef (AJ580407) and SIVden Vpu (CAE46404).
Statistical analysis
All statistical calculations were performed with a one-way
analysis of variances (ANOVA) using GraphPad PrismVersion 4.0.
Table 1. Localization of human and primate tetherins in presence or absence of Vpus.
expressed proteins surface+cytoplasm * perinuclear * diffuse very weak * P (chi-square)
human tetherin 87 13 -
human tetherin+HIV-1 Vpu 11 12 77 ,0.001
C denti tetherin 89 11 -
C denti tetherin+SIVden Vpu 30 70 - ,0.001
C neglectus tetherin 90 10 -
C neglectus tetherin+SIVden Vpu 61 39 - ,0.001
*percentage of cells expresssing tetherin following the indicated pattern.
doi:10.1371/journal.pone.0035411.t001
Antagonism of Tetherin by Lentiviruses
PLoS ONE | www.plosone.org 10 April 2012 | Volume 7 | Issue 4 | e35411Post test comparisons, performed only if p,0.05, were made using
Bonferroni’s Multiple Comparison Test.
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